FDA refocuses COVID vaccine approvals on high-risk groups with new evidence requirements. Medicare fraud case results in sentencing for $3.2M scheme. Lower-income countries increase self-funded vaccine investments. Bipartisan prior authorization reform bill returns in Congress.

Ceresti Health opens a Medicare GUIDE wait list enabling family caregivers nationwide to access tech-enabled dementia care under CMS's new Medicare program launching July 2025. No cost to patients or caregivers.

ASTRO backs bipartisan legislation to reform Medicare Advantage prior authorization, aiming to reduce cancer treatment delays and improve care outcomes.

HHS and CMS unveil Most Favored Nation drug pricing model targeting pharmaceutical manufacturers to align U.S. drug prices with international benchmarks and reduce costs.

The DOJ files a lawsuit accusing insurers and brokerages of illicit kickbacks in Medicare Advantage plan enrollments, raising compliance and regulatory concerns.

Poll in key GOP districts shows strong voter support for stopping tax increases, Medicaid reforms including work requirements, and adjusting state contributions to Medicaid funding.

UnitedHealthcare stops paying commissions on Medicare prescription drug plans sold after June 1, 2025, impacting agents amid rising Medicare Advantage costs and prompting calls for CMS intervention.

Bipartisan legislation aims to cap Medicare coinsurance costs for services at ambulatory surgical centers, promoting cost-effective healthcare and reducing patient expenses.

Analysis of the feasibility, costs, and political dynamics of implementing universal Medicare in the U.S., focusing on insurance costs, coverage expansion, and potential tax structures.

CMS Administrator Dr. Mehmet Oz emphasizes protecting Medicare and Medicaid beneficiaries, targeting fraud, waste, and abuse, and promoting healthy living initiatives under new CMS leadership.